10 Pros and Cons of Antipsychotics in Dementia, A CQC Focused Best Practice Guide

Context for MyQA readers

Antipsychotic medicines can have a place in dementia care, but in adult social care they are also a high risk area for safety, consent, and quality assurance. CQC inspections frequently explore whether psychotropic medicines are used proportionately, reviewed properly, and supported by person centred care planning. This guide sets out 10 practical pros and cons of antipsychotics in dementia, with clear best practice actions and the evidence you should be able to show against CQC Key Lines of Enquiry, the Health and Social Care Act 2008 (Regulated Activities) Regulations 2014, NICE guidance, and good medicines governance. It is written for care home leaders, nurses, senior carers, and quality teams, and it supports both CQC readiness and post inspection improvement.

Important practice note

Only a prescriber can start, stop, or change prescribed medicines. The care home role is to provide robust assessment information, deliver non pharmacological approaches, monitor effects and side effects, and ensure lawful, person centred administration and review.

1. Pro, Short term reduction in severe distress and agitation. Con, Risk of masking unmet need and delaying better solutions

• Pro, In some cases of severe agitation, aggression, or psychosis, antipsychotics may reduce immediate distress and risk, supporting safety for the person and others.
• Con, Behaviour that challenges is often communication of pain, fear, delirium, constipation, infection, sensory overload, trauma, or unmet psychosocial needs. Antipsychotics can suppress signs without addressing root causes.
• CQC focus, KLOE Safe and Responsive, Regulation 9 person centred care, Regulation 12 safe care and treatment.
• Best practice actions, Document an ABC analysis (antecedent, behaviour, consequence), pain assessment, delirium screening indicators, and triggers. Show a structured non pharmacological plan before and alongside medicines.
• Evidence to show, Behaviour support plan, pain tool results, GP or mental health referral notes, staff de escalation guidance, and a documented rationale for any medicine use with review dates.

2. Pro, Management of psychosis symptoms. Con, Increased risk of stroke and mortality in dementia

• Pro, When hallucinations or delusions cause fear, self harm risk, or persistent distress, carefully selected antipsychotics may reduce intensity, particularly when other approaches have not worked.
• Con, Antipsychotics are associated with increased risk of cerebrovascular events and increased mortality in people with dementia. This is a key safeguarding and governance issue.
• CQC focus, KLOE Safe and Effective, Regulation 12, Regulation 13 safeguarding from abuse and improper treatment.
• Best practice actions, Ensure prescriber risk assessment is recorded, including stroke risk factors, falls history, cardiovascular risk, and the least restrictive option principle. Escalate immediately if sudden weakness, facial droop, speech changes, or acute confusion occur.
• Evidence to show, Consent or best interests record, risk benefit discussion notes with family where appropriate, observation charts, and rapid escalation pathways in policies and training.

3. Pro, May reduce immediate risk of harm. Con, Sedation, falls, and loss of independence

• Pro, In rare crisis situations, reducing severe agitation may lower immediate incidents of harm, including injury to the person or others.
• Con, Sedation can increase falls, aspiration risk, pressure damage, deconditioning, and reduced engagement in daily living activities. This can look like a decline in function, but it may be medicine related.
• CQC focus, KLOE Safe and Caring, Regulation 10 dignity and respect, Regulation 12.
• Best practice actions, Define clear target symptoms and measurable outcomes, for example frequency of assaults, duration of distress episodes, sleep disruption. If targets are not met, escalate for review rather than continuing.
• Evidence to show, Falls risk review post initiation, mobility and hydration monitoring, repositioning and skin assessments, and daily notes that differentiate sedation from calmness.

4. Pro, Can support sleep and reduce night time disruption in some cases. Con, Chemical restraint concerns and restrictive practice risks

• Pro, If psychosis or severe anxiety is driving insomnia, an antipsychotic may indirectly improve sleep for a short period while causes are investigated.
• Con, Using antipsychotics primarily to keep someone quiet, to manage staffing pressures, or to control wandering can amount to chemical restraint. This engages human rights considerations and safeguarding duties.
• CQC focus, KLOE Safe, Responsive, and Well led. Regulation 11 consent, Regulation 13, Regulation 17 good governance.
• Best practice actions, Record restrictive practice decision making, confirm least restrictive alternatives tried, and ensure any PRN use has clear criteria, maximum dose, and review triggers. Consider DoLS or LPS implications if restrictions are continuous and not free to leave.
• Evidence to show, Restrictive practice register, PRN protocols, incident analysis, and a clear narrative of how staffing and environment were optimised first.

5. Pro, A structured trial can clarify what helps. Con, Polypharmacy and interaction burden

• Pro, A time limited, monitored trial may help determine whether symptoms are responsive to antipsychotics or whether a different diagnosis or approach is needed.
• Con, Many residents already take multiple medicines. Adding an antipsychotic increases anticholinergic load, interactions, QT prolongation risk, constipation, urinary retention, and confusion.
• CQC focus, KLOE Effective and Safe, Regulation 12, medicines management, and STOMP-STAMP principles.
• Best practice actions, Ensure a pharmacist led medicines review is requested after initiation and at set intervals. Maintain an up to date list of psychotropics, reasons, start date, and review date.
• Evidence to show, MAR audit, medicines review documentation, ECG or physical health checks where indicated, and an outcomes log showing whether the trial met its goals.

6. Pro, May reduce caregiver stress in crisis periods. Con, Risk of normalising medicine first culture and undermining person centred care

• Pro, When someone is in acute distress, a temporary reduction in symptoms can support staff to re establish routine, communication strategies, and meaningful activity.
• Con, If a home drifts into using antipsychotics as a default, staff may reduce focus on life story work, validation, sensory approaches, and environmental design.
• CQC focus, KLOE Caring and Well led, Regulation 9 and 17.
• Best practice actions, Train staff in dementia communication and de escalation, implement meaningful activity schedules, and use personal profiles to tailor approaches. Audit how often non pharmacological strategies are recorded before PRN administration.
• Evidence to show, Training matrix, supervision records, activity plans linked to known triggers, and PRN administration notes that demonstrate alternatives were tried.

7. Pro, Some antipsychotics may be clinically indicated for specific conditions. Con, Misdiagnosis, especially delirium or depression presenting as agitation

• Pro, A resident may have co existing mental illness, for example schizophrenia, bipolar disorder, or severe psychotic depression, where antipsychotics are part of ongoing treatment.
• Con, In older people, delirium from infection, dehydration, medication side effects, or metabolic issues can present with agitation and hallucinations. Treating delirium as dementia related behaviour can delay urgent medical treatment.
• CQC focus, KLOE Effective and Safe, Regulation 12.
• Best practice actions, Have a clear pathway for acute deterioration, including NEWS2 where used locally, hydration checks, urinalysis protocols where appropriate, and prompt GP or urgent care escalation. Ensure mental health history is recorded accurately.
• Evidence to show, Baseline cognition and behaviour description, escalation records, hospital discharge summaries, and multidisciplinary meeting notes.

8. Pro, PRN use can be a short term safety net. Con, PRN drift, variable thresholds, and poor documentation

• Pro, PRN antipsychotics may be prescribed for exceptional circumstances, allowing rapid response to severe distress when agreed criteria are met.
• Con, Without strict governance, PRN can become routine. Different staff may interpret criteria differently, creating inconsistent care and increased risk of over sedation or harm.
• CQC focus, KLOE Safe and Well led, Regulation 12 and 17.
• Best practice actions, Implement PRN protocols that state exact indications, non pharmacological steps required first, minimum interval, maximum daily dose, monitoring requirements, and when to contact the prescriber. Audit PRN use weekly and review patterns.
• Evidence to show, PRN effectiveness charting, post dose observations, debrief notes after incidents, and governance meeting minutes showing actions taken when PRN frequency increases.

9. Pro, Demonstrates proactive risk management when used correctly. Con, Consent, capacity, and best interests errors create high inspection risk

• Pro, When a home follows the Mental Capacity Act properly, involves family or advocates, and documents best interests decisions, antipsychotic use can be lawful, transparent, and ethically justified in limited circumstances.
• Con, Common failings include assuming lack of capacity, failing to document capacity decisions, not recording best interests, not involving representatives, or not reviewing restrictions. These are frequent CQC concerns.
• CQC focus, KLOE Effective and Caring, Regulation 11 consent, Regulation 10 dignity, Regulation 17 governance.
• Best practice actions, Complete decision specific capacity assessments for taking the medicine and for related restrictions. If lacking capacity, document best interests including least restrictive option. Offer IMCA referral when required and ensure families are consulted appropriately.
• Evidence to show, Capacity assessment, best interests meeting record, information given in accessible form, and review dates. Show how the person’s past and present wishes were considered.

10. Pro, Opportunities for measurable quality improvement. Con, Poor review culture leads to long term prescribing without benefit

• Pro, Antipsychotic prescribing can be a strong quality improvement topic. A well led home can reduce inappropriate use, improve wellbeing, and demonstrate excellent governance to CQC.
• Con, Antipsychotics are often continued for months or years with no clear target symptoms, no documented benefit, and no deprescribing plan. This increases harm and indicates weak systems.
• CQC focus, KLOE Well led and Effective, Regulation 17 good governance and continuous improvement.
• Best practice actions, Set a deprescribing expectation at initiation, including a planned review within weeks and a stop or taper plan if no clear benefit. Use regular multidisciplinary reviews and include pharmacists, GPs, mental health services, and family input.
• Evidence to show, An antipsychotic register with start date, indication, target symptoms, review date, outcome, and deprescribing status. Demonstrate learning from audits and incidents.

CQC focused best practice checklist, what good looks like in your evidence

• Assessment, clear description of behaviours, frequency, severity, and impact, plus trigger analysis and physical health checks.
• Person centred planning, life history, communication profile, trauma informed approaches, meaningful activity, and environmental adjustments documented and used.
• Least restrictive practice, non pharmacological interventions tried and evaluated first, restrictive practice decisions recorded, and DoLS or LPS considerations addressed where relevant.
• Medicines governance, accurate MARs, PRN protocols, stock control, covert administration policy if applicable, and pharmacist review evidence.
• Monitoring, documented benefits and side effects, falls and sedation monitoring, physical observations where indicated, and clear escalation triggers.
• Consent and MCA, decision specific capacity assessment, best interests decisions, involvement of representatives and advocates, and regular review dates.
• Governance and leadership, audits, action plans, learning shared with staff, supervision, and training compliance, including dementia, MCA, safeguarding, and medicines competence.

How MyQA would frame an audit question set for CQC readiness

• For each resident on an antipsychotic, can you show the clinical indication, target symptoms, start date, and planned review date?
• Can staff describe and evidence the non pharmacological strategies that are tried first, and do notes show they were used consistently?
• Is PRN use low, justified, and clearly documented with effect and side effect monitoring?
• Are capacity and best interests records decision specific, current, and aligned with the care plan and restrictions in practice?
• Do governance meetings review psychotropic use trends and take action, for example training, GP reviews, environmental changes?

Conclusion

Antipsychotics in dementia care sit at the intersection of safety, ethics, law, and quality. The potential short term benefits are real in a small group of people, but the risks are significant and frequently visible to CQC through outcomes, records, and staff practice. The strongest CQC position is built by clear clinical rationale, robust MCA compliance, high quality non pharmacological support, careful monitoring, and disciplined review and deprescribing. If your home can evidence those elements consistently, you will be well placed for CQC readiness and for improved resident wellbeing.